2-(2-Fluoro-4-nitroanilinoethyl)benzaldehyde, C15H13 FN2O3, exists as the aldehyde form with essentially planar and parallel benzaldehyde and nitroaniline fragments, which are Linked through an ethylene bridge joining the aniline N atom and an ortho-C atom of the benzaldehyde fragment. N-(2-Fluoro-4-nitrophenyl)-1-methoxy-1,2,3,4-tetrahydroisoquinoline, C16H15FN2O3, obtained as a methanolysis product on attempted recrystallization of 2-(2-fluoro-4-nitroaniIinoethyl)benzaldehyde from methanol solution, consists of essentially planar nitrobenzene and non-planar tetrahydroquinoline fragments, which are Linked directly through the para-C atom of the former and the endocyclic N atom of the latter.
[EN] 1H-ISOQUINOLINE-OXAZOLIDINONE DERIVATIES AND THEIR USE AS ANTIBACTERIAL AGENTS [FR] DERIVES DE 1H-ISOQUINOLINE-OXAZOLIDINONE, ET LEUR UTILISATION COMME AGENTS ANTIBACTERIENS
[EN] 1H-ISOQUINOLINE-OXAZOLIDINONE DERIVATIES AND THEIR USE AS ANTIBACTERIAL AGENTS<br/>[FR] DERIVES DE 1H-ISOQUINOLINE-OXAZOLIDINONE, ET LEUR UTILISATION COMME AGENTS ANTIBACTERIENS
申请人:ORCHID CHEMICALS & PHARM LTD
公开号:WO2003106454A1
公开(公告)日:2003-12-24
The present invention provides novel compounds of the general formula (I), their
derivatives, their analogs, their tautomeric forms, their stereoisomers,
their polymorphs, their hydrates, their solvates, their pharmaceutically
acceptable salts and pharmaceutically acceptable compositions containing
them. The present invention more particularly provides novel oxazolidinone
derivatives of the general formula (I)
A method of treating a condition associated with the CB-1 receptor, in particular obesity, by administering an effective amount of an aryl urea CB-1 receptor modulating compound to a subject in need of such treatment.
A method of treating a condition associated with the CB-1 receptor, in particular obesity, by administering an effective amount of an aryl urea CB-1 receptor modulating compound to a subject in need of such treatment.